We are live on ! Find out more
ATYR icon

aTyr Pharma

22 hedge funds and large institutions have $22.9M invested in aTyr Pharma in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

24% more capital inflows, than outflows

Capital inflows: $3.88M | Capital outflows: $3.13M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.16% less ownership

Funds ownership: 58% → 57.84% (-0.16%)

4% less funds holding

Funds holding: 23 → 22 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ATYR Hedge Fund Activity: Q4 2020 in Review

22 of the 5,679 institutional investors tracked by Wall St. Rank reported a position in aTyr Pharma (ATYR) for Q4 2020, worth a combined $22.9M — up 23% from $18.6M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ATYR and 5 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 7 added.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $1.46M. The largest seller was Viking Global Investors, exiting entirely with an estimated $1.9M sold.

  • 22 institutional investors held aTyr Pharma (ATYR) as of Q4 2020, down from 23 in Q3 2020.
  • Funds reported $22.9M of aTyr Pharma stock for Q4 2020, up 23% quarter-over-quarter.
  • 5 funds opened new aTyr Pharma positions in Q4 2020 and 6 closed out, a net change of -1 holder.
  • The largest aTyr Pharma buyer in Q4 2020 was Ikarian Capital, an estimated $1.46M added.
  • The largest aTyr Pharma seller in Q4 2020 was Viking Global Investors, an estimated $1.9M sold.

Based on aggregated 13F filings for Q4 2020.